Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

12:12 BST Flexipharm Austrading Announces Launch of Arsenic Trioxide Phebra (Arsenic Trioxide 1mg/ml Concentrate for Solution for Infusion)

Flexipharm Austrading the UK specialty pharmaceutical company focused on supplying the NHS with Better. Critical Care Medicines, today announced the...


11:00 BST Results from Spatz Medical FDA clinical trials confirm that Spatz3, the only Adjustable Gastric Balloon, delivers the highest success rates of all gastric balloons

Spatz Medical today announced the FDA trial results of its innovative adjustable gastric balloon. The results demonstrate that the Spatz3 balloon is...


08:00 BST New Post-hoc Analysis Shows Adding UPTRAVI®▼ (selexipag) Versus Placebo Improved Long-term Clinical Outcomes Regardless of Time of Treatment Initiation, and Demonstrated an Even More Pronounced Treatment Effect When Initiated Early

Actelion Pharmaceuticals Ltd, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, has presented results of a post-hoc exploratory...


07:00 BST Rinri Therapeutics Secures £1.4 Million Seed Funding to Advance Its Novel Regenerative Cell Therapy to Treat Sensorineural Hearing Loss

Rinri Therapeutics, a biotechnology company developing a novel cell-based therapy to restore hearing, announced today that it successfully secured £1....


05:01 BST A New Approach to Treating Alzheimer's Disease Receives Major NIA Backing

T3D Therapeutics, a clinical stage drug development company engaged in the development of T3D-959 (the "Company"), a new orally administered...


17 May, 2019, 13:00 BST Therachon to Present Data from Ongoing Phase II Study of Apraglutide for Short Bowel Syndrome (SBS) at Digestive Disease Week

Therachon AG ("Therachon"), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative...


16 May, 2019, 21:30 BST Jazz Pharmaceuticals to Present New Data at Upcoming ASCO Annual Meeting and EHA Congress

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that it will present data from across its hematology/oncology portfolio and pipeline at the...


16 May, 2019, 16:00 BST ChemPartner and Berkeley Lights Take Next Step in B Cell Antibody Discovery Collaboration

Shanghai ChemPartner a leading global Contract Research Organization (CRO), along with Berkeley Lights, Inc. (BLI), the leader in digital cell...


16 May, 2019, 14:18 BST Oncopeptides Announces Acceptance of Four Abstracts Highlighting Melflufen Clinical Programs for Presentation at 24th EHA Congress in June 2019

Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that a total of four abstracts have been accepted for presentation at the 24th Congress of...


16 May, 2019, 07:00 BST 4D Presents Phase Ib Clinical Data on Thetanix®

4D pharma plc (AIM: DDDD), a pharmaceutical company focusing on the development of Live Biotherapeutics, today announced that data from the completed ...


16 May, 2019, 00:29 BST Alligator Bioscience: ADC-1013 Clinical Phase I Data to be Presented at ASCO

Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces that Janssen Biotech, Inc. (Janssen) will present data from a Phase I clinical study...


16 May, 2019, 00:10 BST Oncopeptides Announces Melflufen Data Accepted for Presentation at 2019 ASCO Annual Meeting

Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that data from its Phase 1/2 O-12-M1 study evaluating melflufen, a lipophilic...


15 May, 2019, 23:36 BST Cantargia: Abstract Published for the Oral Presentation of Antibody CAN04 Phase I Data at ASCO

Cantargia AB today announces that the abstract of the upcoming oral presentation of CAN04 phase I clinical data at the 2019 ASCO Annual Meeting is...


15 May, 2019, 23:35 BST BerGenBio to Present New NSCLC and AML Clinical Data and Biomarker Data From Phase II Development Programme With Selective AXL Inhibitor Bemcentinib at ASCO 2019

Two peer reviewed abstracts on Phase II clinical data with bemcentinib accepted for presentation at ASCO 2019 Non-Small-Cell Lung Cancer (NSCLC)...


15 May, 2019, 17:02 BST GlobalBetterHealth.org Promotes New WHO Guidelines to Reduce Risk of Dementia While Focusing on Better Health at Lower Costs

The UN's World Health Organization (WHO) released the latest Risk Reduction Guidelines for Alzheimer's at today's Dementia Forum X. WHO confirmed the ...


15 May, 2019, 13:00 BST IO Biotech Initiates Global Phase 2 Portion of Clinical Trial For T-win® Immunotherapy in Non-small Cell Lung Cancer

IO Biotech, a clinical-stage biopharmaceutical company developing novel, immune modulating anti-cancer therapies based on its proprietary T-win®...


15 May, 2019, 12:45 BST New Study Demonstrates Clinical Utility of Liquid Biopsy for Cancer Monitoring

Growing scientific evidence supports liquid biopsy as a valuable tool for monitoring treatment response in patients with cancer. A new retrospective...


15 May, 2019, 11:32 BST Ping An completes multi-center clinical trials for world's first intelligent OCT retinal disease screening system

Ping An Insurance (Group) Company of China, Ltd. ("China Ping An", "Ping An", the "Group" or the "Company"; stock codes: HKEX 2318 and SSE 601318) is ...


14 May, 2019, 07:43 BST Cantargia Announces New Pre-clinical Results Showing Consistent Positive Effects of the Antibody CAN04 When Combined with Platinum-based Chemotherapies

Cantargia AB today announces new pre-clinical results from the antibody CAN04 (nidanilimab) in combination with platinum-based chemotherapies....


13 May, 2019, 16:25 BST Frost & Sullivan Publishes Annual Update on BioLineRx

The TASE analysis project was launched in 2016 in order to raise investor awareness to TASE listed technology and life-science companies and the...


13 May, 2019, 09:18 BST Atlantis Healthcare Evolves Health Psychology Approach To Optimise Medication Adherence Research and Solutions

Atlantis Healthcare, a global leader in personalised health solutions, announced the adoption of a new health psychology approach to guide...


13 May, 2019, 08:00 BST 4D Announces Participation in Neuro4D Conference, Frankfurt, Germany

4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announces its participation in the Neuro4D ...


10 May, 2019, 18:45 BST Positive Phase II Data Further Highlights Clinical Proof of Concept for Evobrutinib, First Oral Bruton´s Tyrosine Kinase (BTK) Inhibitor to Report Positive Phase II Clinical Results in MS

Merck, a leading science and technology company, today announced new 48-week results of the double-blind, randomised, placebo-controlled, Phase II...


08 May, 2019, 13:45 BST Sanofi Announces Licensing of Dupixent® ▼ (dupilumab) in the EU for the Treatment of Severe Asthma With Type 2 Inflammation[1]

FOR UK MEDIA ONLY The first biologic licensed in the EU for severe asthma with type 2 inflammation, as characterised by raised blood eosinophils...


08 May, 2019, 12:50 BST Kanazawa University Research: Radioisotope Couple for Tumor Diagnosis and Therapy

Researchers at Kanazawa University report in ACS Omega a promising combination of radioisotope-carrying molecules for use in radiotheranostics — a...